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AT A GLANCE COMMENTARY 
Scientific Knowledge on the Subject 
Previous studies have shown inconsistent results regarding the association of 
overweight/obesity with lung function in children and adolescents, likely because most have 
defined overweight/obesity using the body mass index (BMI). However, the BMI does not 
distinguish between different components of body weight (e.g. fat mass and lean body mass). 
The few studies that have assessed the role of body composition on lung function in children 
and adolescents are all cross-sectional, based on specific populations (asthmatics, obese 
children, cystic fibrosis) and most did not consider the role of relevant confounders, such as 
previous lung function levels, pubertal status, physical activity and diet. 
 
What This Study Adds to the Field 
This longitudinal study uses data from a large population-based birth cohort with repeated 
objective measures of body composition and information on numerous relevant confounders 
to show that higher lean body mass during childhood and adolescence is associated with 
higher levels of FEV1, FVC and FEF25-75 at 15 years and with higher growth rates of these 
parameters from 8 to 15 years. Higher fat mass was associated with lower levels and growth 
rates of FEV1 and FEF25-75 only in boys and lower levels of FEV1/FVC in both sexes. Our 
study highlights the importance of assessing body composition, and not just BMI, when 
studying the respiratory health effects of body weight in children and adolescents. 
 
ONLINE DATA SUPPLEMENT 
This article has an online data supplement, which is accessible from this issue's table of 
content online at www.atsjournals.org. 
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ABSTRACT 
Rationale: Body composition changes throughout life may explain the inconsistent 
associations reported between body mass index (BMI) and lung function in children. 
Objectives: To assess the associations of body weight and composition trajectories from 7 to 
15 years with lung function at 15 years and lung function growth between 8 and 15 years.  
Methods: Sex-specific BMI, lean body mass index (LBMI) and fat mass index (FMI) 
trajectories were developed using Group-Based Trajectory Modeling on data collected at least 
twice between 7 and 15 years from 6,964 children (49% boys) in the UK Avon Longitudinal 
Study of Parents and Children birth cohort. Associations of these trajectories with post-
bronchodilation lung function parameters at 15 years and with lung function growth rates 
from 8 to 15 years were assessed using multivariable linear regression models, stratified by 
sex, in a subgroup with lung function data (n=3,575).  
Measurements and Main Results: For all body mass measures we identified parallel 
trajectories that increased with age. There was no consistent evidence of an association 
between the BMI trajectories and lung function measures. Higher LBMI trajectories were 
associated with higher levels and growth rates of FVC, FEV1, and FEF25-75 in both sexes (e.g. 
boys in the highest LBMI trajectory had on average a 0.62L [95%CI: 0.44; 0.79, p-
trend<0.0001] higher FVC at 15 years than boys in the lowest trajectory). Increasing FMI 
trajectories were associated with lower levels and growth rates of FEV1 and FEF25-75 only in 
boys and lower levels of FEV1/FVC in both sexes.  
Conclusions: Higher lean body mass during childhood and adolescence is consistently 
associated with higher lung function at 15 years in both sexes, whereas higher fat mass is 
associated with lower levels of only some lung function parameters. 
Abstract word count: 284 
Key words: ALSPAC, children, epidemiology, respiratory health 
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INTRODUCTION 
Lung function is a powerful marker of overall health and a significant predictor of future 
morbidity and mortality in the general population (1). As lung function levels in childhood 
predict adult lung function, identifying factors that influence the development of lung 
function in childhood is important. Given the current global increase of childhood overweight 
and obesity, several studies have assessed their associations with lung function, but findings 
are inconsistent. Some studies report a positive association of overweight and obesity, as 
measured by body mass index (BMI), with lung function, while others show a negative 
association (2–8). An important limitation of these studies is that they did not distinguish 
between lean body mass and fat mass, both of which contribute to the composite measure 
BMI. 
Some studies have examined body composition measures in relation to lung function, but they 
were all cross-sectional, most focused on specific populations (cystic fibrosis, obese or 
asthmatic children) and most did not consider pubertal status, physical activity or diet as 
relevant confounders (9–16). Furthermore, they only considered measurements at a single 
time point, and did not capture changes in the proportion of the different components of body 
weight (e.g., fat mass, lean body mass, bone mass) that occur over time and vary with sex 
(17).  
Here we assess the association of body weight and composition trajectories, defined using 
repeated anthropometric and dual-energy X-ray absorptiometry (DXA) scanner measures 
taken from age 7 to 15 years, with lung function at 15 years and lung function growth 
between 8 and 15 years, using data from the UK population-based Avon Longitudinal Study 
of Parents and Children (ALSPAC) birth cohort. This approach overcomes the limitations of 
previous research. 
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Some of the results of this study have been previously reported in the form of an abstract to 
the European Respiratory Society annual congress (18). 
 
METHODS 
Complete details are provided in the online supplement.  
Study population 
We used data from the 14,305 singleton births recruited in the population-based UK ALSPAC 
birth cohort, previously described (19, 20). For the identification of body weight and 
composition trajectories, we included children with at least two repeated measures of body 
weight and composition between the ages of 7 and 15 years (n=6,964). Children who 
additionally had lung function measures at age 15 years were used to evaluate associations of 
body weight and composition trajectories with lung function measures at 15 years (n=3,575) 
(see Figure E1in the online supplement). 
The ALSPAC Ethics and Law Committee and the Local Research Ethics Committees gave 
ethical approval. All participants and their parents/guardians provided written informed 
consent. 
Measures 
Body weight, height and composition were assessed following standardised procedures (21). 
Weight and height were measured every year from age 7 to 15 years. Body composition (total 
lean body mass, total fat mass, and total bone mass) was measured using a Lunar Prodigy 
DXA scanner at age 9, 11, 13, and 15 years. BMI, lean body mass index (LBMI) and fat mass 
index (FMI) were calculated by dividing body weight, total lean body mass and total fat mass 
(kg) by height (m) squared, respectively. 
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Lung function was measured by spirometry at 8 and 15 years (Vitalograph 2120; Vitalograph, 
Maids Moreton, United Kingdom) according to American Thoracic Society standards (22). At 
15 years, lung function was measured before and after bronchodilation with salbutamol. 
Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), and forced 
expiratory flow at 25% and 75% of FVC (FEF25-75) were obtained and the FEV1/FVC ratio 
was calculated. The outcomes of the analysis were: post-bronchodilation lung function 
measures at 15 years and rate of lung function growth from age 8 to 15 years (calculated as 
(pre-bronchodilation lung function at 15 years – pre-bronchodilation lung function at 8 
years)/time of follow-up in years).   
We collected information, at different time points, on maternal social class, birthweight, 
gestational age, breastfeeding, tobacco exposure (during pregnancy, childhood and first hand), 
total dietary energy intake, physical activity (by accelerometer), asthma doctor-diagnosis and 
pubertal status.  
Statistical analysis 
We conducted all analyses stratified by sex as body weight and composition as well as lung 
function have been found to differ across sexes. 
We identified BMI trajectories by applying a Group-Based Trajectory Modeling approach 
(23) using yearly data from ages 7 to 15 years, and LBMI and FMI trajectories using data 
from ages 9, 11, 13 and 15 years. As the distribution of BMI and FMI was right-skewed, we 
applied the natural log-transformation to all body weight and composition measures prior to 
the identification of the trajectories. The assigned trajectory was used as the exposure variable 
in all subsequent analyses. 
Associations of body weight and composition trajectories with post-bronchodilation lung 
function measures at age 15 years and lung function growth rates from age 8 to 15 years were 
examined using multivariable linear regression. The final multivariable models included 
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adjustments for maternal social class, maternal smoking during pregnancy, birth weight, any 
breastfeeding, pubertal status as well as age and height at 15 years. We additionally adjusted 
all models for lung function levels at 8 years to reduce potential reverse causality. The models 
for the LBMI and FMI trajectories were also mutually adjusted.  
We conducted several sensitivity analyses to assess the sensitivity of our estimates to varying 
assumptions regarding selection bias, information bias and confounding (see online 
supplement).  
All analyses were conducted using Stata/SE 12.0 (StataCorp, College Station, TX, USA).  
 
RESULTS 
Characteristics of study sample 
We included 6,964 children (49.0% boys) in the identification of the body weight and 
composition trajectories. These children were more likely to be girls, have a higher socio 
economic status, a higher birth weight, a higher proportion of breastfeeding, and lower 
maternal smoking exposure than the children not included in the present analysis but 
participating in ALSPAC. Additionally, boys had lower LBMI and girls had lower BMI at 9 
years when compared to the children not included in our analysis (see Table E1 in the online 
supplement). A subset of the included children with available spirometry was used to analyze 
the associations of body weight and composition trajectories with lung function at 15 years 
(n=3,575, 47.2% boys). The children in this subgroup were more likely to be girls and have a 
higher socio-economic status, a higher proportion of breastfeeding, and lower maternal 
smoking exposure than those not included, but they did not differ in terms of body weight and 
composition trajectories or in baseline lung function measures (see Table E2 in the online 
supplement).  
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Table 1 shows the main characteristics of the sample subset used in the association analysis 
with lung function. Approximately half of the mothers had a high social class and around 16% 
smoked during pregnancy. Boys had significantly higher lung function levels (FVC, FEV1, 
and FEF25-75) at 8 and15 years and higher lung function growth between 8 and 15 years than 
girls. Figure 1 and table 2 show the body weight and composition characteristics of the 
children across ages. Body weight was composed mainly of lean body mass at all ages for 
both boys and girls. The amount of lean body mass and fat mass changed over time, although 
this pattern differed by sex. Boys had lower BMI and FMI, but higher LBMI, than girls at all 
ages.   
 
Body weight and composition trajectories 
In both boys and girls, we identified four parallel BMI trajectories from 7 to 15 years. For 
both sexes, BMI increased with age (Figure 2 and Table E3 in the online supplement). 
According to the WHO reference cut-offs (24), we labelled these trajectories as ‘normal-low’, 
‘normal-high’, ‘overweight’, and ‘obese’. In boys, the median BMI increased from 14.6 
kg/m2 at age 7 years to 18.3 kg/m2 at age 15 years in the ‘normal-low’ BMI trajectory and 
from 20.1 kg/m2 at age 7 years to 27.7 kg/m2 at age 15 years in the ‘obese’ BMI trajectory (see 
Table E3 in the online supplement).  
 For LBMI, we identified four parallel trajectories from age 9 to 15 in both sexes (Figure 2 
and Table E4 in the online supplement). According to reference curves for body composition 
in children (25), we labelled these trajectories as ‘low’, ‘medium-low’, ‘medium-high’, and 
‘high’. Median LBMIs were consistently greater in boys than girls for all trajectories. Also, 
the increase per year of LBMI was steeper in boys than girls, specifically between age 11 and 
15 years.  
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For FMI, we identified four parallel trajectories from age 9 to 15 in both sexes, which we 
labelled ‘low’, ‘medium-low’, ‘medium-high’ and ‘high’(25) (Figure 2 and Table E5 in the 
online supplement). Median FMIs were consistently greater in girls than boys for all 
trajectories. In boys, FMI levels consistently increased from age 9 to 11 years and then 
slightly declined from age 11 years onwards. In girls, FMI consistently increased up to 15 
years in all trajectories.  
 
Associations of body weight and composition trajectories with post-bronchodilation lung 
function at 15 years 
Adjusted associations between the BMI trajectories and post-bronchodilation lung function 
measures at age 15 years were inconsistent. Significant associations were only apparent for 
some trajectories and some lung function parameters (Figure 3 and Table E6 in the online 
supplement). 
Both boys and girls in the highest LBMI trajectories had higher FVC, FEV1, and FEF25-75. The 
association between the LBMI trajectories and these lung function variables exhibited a linear 
dose-response pattern (e.g. boys in the ‘medium-low’, ‘medium-high’, and ‘high’ LBMI 
trajectory groups had on average a 0.24L 95%CI [0.09; 0.39], 0.44L [0.29; 0.59], and a 0.62L 
[0.44; 0.79] higher FVC respectively than boys in the ‘low’ LBMI trajectory [p-
trend<0.0001]). We did not find any statistically significant association between the LBMI 
trajectories and the FEV1/FVC ratio for either sex (Figure 3 and Table E6 in the online 
supplement).  
Boys in the ‘high’ FMI trajectory had lower FEV1 (-0.14L, [-0.26; -0.01]; p-value: 0.032) than 
boys in the “low” FMI trajectory and there was a trend towards lower FEF25-75 with higher 
FMI trajectories (p-trend: 0.028). We did not find any statistically significant association 
between FMI trajectories and FEV1 or FEF25-75 in girls, nor between FMI trajectories and 
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FVC in boys or girls. Both boys and girls who were in the highest FMI trajectory exhibited 
lower FEV1/FVC ratios (Figure 3 and Table E6 in the online supplement). 
All sensitivity analyses showed very similar results for LBMI (see Tables E8 to E13 in the 
online supplement), even after additional adjustment for physical activity and total energy 
intake (see Table E8 in the online supplement). For the FMI trajectories, the association 
between a higher FMI trajectory and a lower FEV1/FVC ratio was maintained in all sensitivity 
analysis, but the associations with the other lung function parameters were more instable: 
first, the magnitude of the associations of FMI with FEV1 and FEF25-75 (observed only in boys 
in the main analysis) was attenuated in some of the analyses and second, an association 
appeared between the ‘high’ FMI trajectory and post-bronchodilation FVC in girls only in 
some of the models.      
Associations of body weight and composition trajectories with pre-bronchodilation lung 
function growth rates from age 8 to 15 years 
After adjusting for relevant confounders, there was no evidence of a consistent association 
between BMI trajectories and lung function growth rate (Figure 4 and Table E7 in the online 
supplement).   
Increasing LBMI was consistently associated with higher growth rates of FVC, FEV1 and 
FEF25-75 in both sexes, and this association exhibited a linear dose-response pattern (e.g. in 
boys included in the ‘high’ LBMI trajectory FVC increased 90.3 mL/year 95% CI [65.0; 
115.7] higher than in boys in the ‘low’ LBMI trajectory [p-trend<0.0001]). 
Boys in the ‘high’ (but not ‘medium-low’ or ‘medium-high’) FMI trajectory exhibited a lower 
growth rate of FEV1 (-23.2mL/year, 95%IC [-40.7; -5.8]; p-value: 0.009) than boys in the 
‘low’ FMI and there was a trend towards lower FEF25-75  with higher FMI trajectories (p-
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trend: 0.045). We did not find any association between FMI trajectories and growth rate of 
FEV1 or FEF25-75 in girls, nor between FMI and growth rate of FVC in boys or girls.  
All sensitivity analyses showed very similar results for LBMI (see Tables E14 to E18 in the 
online supplement). For the FMI trajectories, the magnitude of the associations with the 
growth rate of FEV1 and FEF25-75 (observed only in boys in the main analysis) was attenuated 
in some of the analyses (see Tables E14 to E18 in the online supplement) and there was a 
statistically significant linear trend between FMI trajectories and the growth rate of FVC in 
girls when we used z-scores (see Table E18 in the online supplement). 
DISCUSSION 
To our knowledge, this is the first study to show that body composition trajectories from 
childhood to adolescence relate to lung function levels at 15 years and lung function growth 
rates from age 8 to 15 years in a large population-based birth cohort. Specifically, we found 
that (i) higher LBMI was associated with higher levels and growth rates of FVC, FEV1 and 
FEF25-75 in both sexes, and (ii) higher FMI was related to lower levels and growth rates of 
FEV1 and FEF25-75 in boys and to a lower FEV1/FVC ratio in both sexes. 
Our finding that a higher lean body mass is related to higher lung function is consistent with 
observations from previous cross-sectional studies in children and adolescents (9, 14, 15). We 
show this association longitudinally, reducing the potential for reverse causation, and after 
adjustment for relevant confounders, such as physical activity, diet and pubertal status. High 
lean body mass may reflect increased strength of the diaphragm and chest wall during 
expansion and contraction during breathing (26), which could produce a greater FVC, FEV1 
and FEF25-75 (27). Physical activity (leading to higher levels of lean body mass) (28) could be 
the ultimate driver of higher lung function measures, but all associations  remained stable 
after adjustment for physical activity (measured by accelerometer). Consequently, other 
mechanisms are likely to play a role. 
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Our study is the first to show an association between higher fat mass and increased airflow 
limitation (as measured by a lower FEV1/FVC ratio) in both sexes. This association is 
difficult to interpret given the inconsistency of the associations between the fat mass 
trajectories and each of FEV1 and FVC. Similar inconsistencies have been observed in studies 
on children which have used BMI as a measure of overweight/obesity; higher BMI appears to 
be consistently related to a lower FEV1/FVC ratio (4, 7), but the direction of the associations 
between BMI with FEV1 and FVC varies by study. One explanation could be that the fat mass 
component is the one that is contributing to the inconsistent results observed for BMI. We 
also hypothesise a mediating role of inflammation, which could explain the stronger effect of 
fat mass on airway calibre than on lung capacity. Since adipose tissue is a source of 
inflammatory mediators (29), local effects of inflammation on lung tissues could lead to 
reductions in airway diameter. A similar mechanism has also been proposed to explain the 
link between obesity and asthma (30).    
Higher FMI trajectories also were related, only in boys, to lower FEV1 and FEF25-75. A 
previous cross-sectional study also reported an association between body adiposity (assessed 
through bioelectrical impedance) and FEV1 and FVC only in boys (15). One explanation 
could be related to sex differences in fat distribution. Boys, unlike girls, tend to accumulate 
fat in the abdominal region (31), which via mechanics, may reduce the expiratory reserve 
volume, in turn leading to expiratory flow limitation (32).  
The results of the present study have important research and public health implications. First, 
our study highlights the importance of assessing body composition, and not just BMI, when 
studying the health effects of body weight in children and adolescents. Failure to do this has 
likely contributed to the conflicting findings from multiple studies that have reported 
associations between overweight/obesity and lung function in children and adolescents (2–8). 
BMI, a measure based simply on height and total body mass, is unable to distinguish between 
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lean body mass and fat mass, and their relative proportions that vary greatly by age and sex 
during adolescence as a consequence of puberty (17). In fact, we found important sex 
differences in the levels and changes over time of lean body mass and fat mass (Figures 1 and 
2). Compared to boys, girls had higher levels of fat mass at all ages and showed a higher age-
related increase of FMI for all trajectories. In contrast, boys had higher levels of lean body 
mass at all ages and their age-related increase in LBMI was steeper than in girls. Second, our 
study shows that body composition in childhood and adolescence influences the development 
of lung function and, consequently, may affect future respiratory health. Since body 
composition tracks from childhood to adulthood (17) and is affected by modifiable lifestyles 
factors such as physical activity and diet (21, 28, 33), public health strategies promoting 
healthy lifestyles in early childhood may improve lung function and reduce respiratory 
morbidity in adult life. 
A limitation of the present study is the potential selection bias produced by the fact that 
children included in the study were more likely to be girls, have a higher socio-economic 
status, a higher birth weight, a higher proportion of breastfeeding, and lower maternal 
smoking exposure than those excluded. Because these factors have been previously associated 
with lung function, our associations could be underestimates of the true associations in the 
general population. However, since most of the attrition occurred between birth and age 7 
years, the observed associations (which are based largely on data collected from 7 to 15 years) 
are less likely to be affected by the loss to follow-up. Also, the regional basis of the ALSPAC 
cohort may not allow the generalizability of our results to populations with more ethnic 
variability. Finally, it is possible that using group-based trajectory modelling for identifying 
trajectories of body weight and composition may have smoothened the data.   
Important strengths of the present research are the large sample size and the longitudinal 
design, which, together with the adjustment for baseline lung function (both for levels of lung 
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function and lung function growth rates), reduces the possibility of reverse causation. 
Importantly, we measured body composition using DXA, which is substantially more valid 
than other methods (such as bioelectrical impedance or skinfolds). Finally we had detailed 
information of several covariates from both the children and their parents, which allowed us 
to account for a wide range of potential confounders, including physical activity, diet and 
baseline lung function.  
In conclusion, this cohort study shows that body composition in childhood and adolescence is 
associated with lung function in adolescence, and consequently, it may also influence 
respiratory health in later life. Specifically, we found that lean body mass during childhood 
and adolescence relates to higher lung function in adolescent boys and girls, while fat mass 
relates to lower lung function in boys only. This study shows that public health policies 
aiming to reduce respiratory morbidity should target body composition in addition to body 
weight.  
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Figure 1. Distribution of body weight components from age 9 to 15 years, stratified by 
sex. 
Body weight components were measured using a dual-energy X-ray absorptiometry (DXA) 
scanner. The presented values are the median of total lean body mass, total fat mass and total 
bone mass.  
Figure 2. Sex-specific body weight and composition trajectories from 7 to 15 years. 
The percentage of the sample that is included in each trajectory is reported in the legend. The 
y-axis represents the natural log-transformed levels of BMI, LBMI and FMI (the equivalent 
raw values can be calculated by exponentiation of the log-transformed values [i.e. BMI raw 
value = exp(log BMI)]). Definition of abbreviations: BMI, body mass index; FMI, fat mass 
index; LBMI, lean body mass index.  
Figure 3. Sex-specific associations of body weight and composition trajectories with 
post-bronchodilation lung function measures at age 15 years. 
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Definition of abbreviations: BMI, body mass index; FEF25-75 forced expiratory flow at 25-
75%; FEV1, volume expired in the first second; FMI, fat mass index; FVC, forced vital 
capacity; LBMI, lean body mass index; 95% CI, 95% confidence intervals; β, estimate of 
regression coefficient. 
Models are adjusted for maternal social class, maternal smoking during pregnancy, birth 
weight, breastfeeding, lung function measures at 8 years, pubertal status (age at menarche for 
girls and voice break status at age 15 years for boys), as well as age and height at 15 years. 
Models for FMI and LBMI are also mutually adjusted. 
Figure 4. Sex-specific associations of body weight and composition trajectories with pre-
bronchodilation lung function growth rates from age 8 to 15 years. 
Definition of abbreviations: BMI, body mass index; FEF25-75 forced expiratory flow at 25-
75%; FEV1, volume expired in the first second; FMI, fat mass index; FVC, forced vital 
capacity; LBMI, lean body mass index; 95% CI, 95% confidence intervals; β, estimate of 
regression coefficient. 
Models are adjusted for maternal social class, maternal smoking during pregnancy, birth 
weight, breastfeeding, lung function measures at 8 years, pubertal status (age at menarche for 
girls and voice break status at age 15 years for boys), as well as age and height at 15 years. 
Models for FMI and LBMI are also mutually adjusted. 
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 § Derived using the International Fetal and New-born Growth Consortium for the 21stCentury standards. Note that 15 children had missing 
values for birth weight z-score because they did not have information for gestational age, which should be included in the equation. ¶ 
Derived using the WHO Child Growth Standards. * Derived using the Global Lung Initiative equations. ǂ Rate of lung function growth for 
each parameter was calculated as: (pre-bronchodilation lung function measure at 15 years - pre-bronchodilation lung function measure at 8 
years)/time of follow-up in years. Definition of abbreviations: FEF25-75 , forced expiratory flow at 25-75%; FEV1, volume expired in the first 
second; FVC, forced vital capacity; MVPA, moderate to vigorous physical activity; P25-P75, 25th and
 75th percentiles; SD, standard 
deviation; - -, Not relevant 
p-value from the Chi-squared test, Student’s t-test, or Mann-Whitney test comparing distributions across sexes. Bold: p-value <0.05  
Table 1. Characteristics of the participants used to assess associations of body weight and composition 
trajectories with lung function at 15 years 
Mean (SD), Median (P25-P75) or n (%) 
n 
(N=3,575) 
Boys 
(n=1,687) 
Girls 
(n=1,888) 
p-value 
Potential confounders     
Maternal social class 2,941    
   Professional and intermediate  1,322 639 (46.2) 683 (43.8) 0.712 
   Skilled non-manual  1,179 554 (40.1) 625 (40.1)  
Skilled manual, partly, and unskilled  440 190 (13.7) 250 (16.1)  
Maternal smoking during pregnancy 3,278 260 (16.8) 290 (16.7) 0.930 
Birth weight (grams)  3,381 3,485 (3,160-3,860) 3,402 (3,120-3,700) <0.0001 
Birth weight (z-score)§ 3,366 0.5 (1.1) 0.5 (1.0) 0.686 
Gestation (weeks) 3,425 40 (39-41) 40 (39-41) <0.0001 
Ever breastfed  3,335 1,385 (88.1) 1,521 (86.3) 0.137 
Total energy intake (kcal) at 7 years  3,004 1,758 (1586-1973) 1,630 (1457-1819) <0.0001 
Wear-time in MVPA (minutes) at 11 years 2,955 24.4 (15.4-36.5) 15.6 (9.4-24.7) <0.0001 
Smoking at 14 years  2,790 42 (3.4) 109 (7.0) <0.0001 
Age at 15 years (years) 3,575 15.3 (15.3-15.5) 15.3 (15.3-15.5) 0.015 
Height at 15 years (centimetres) 3,538 174.4 (169.4-179.2) 164.4 (160.6-168.6) <0.0001 
Height at 15 years (z-score)¶ 3,538 0.4 (1.0) 0.4 (0.9) 0.017 
Lifetime doctor-diagnosed asthma 3,573 443 (26.3) 422 (22.4) 0.006 
Pubertal status     
Age at menarche (years) 1,701 -- 12.7 (11.8-13.6)  
Voice break status at age 15 years 1,649    
Not yet started 218 218 (13.2) --  
Starting to break 505 505 (30.6) --  
Completely broken 926 926 (56.2) --  
Lung function measures (Raw data)     
8 years (pre-bronchodilation)     
FVC (L) 3,078 2.0 (0.3) 1.8 (0.3) <0.0001 
FEV1 (L) 3,045 1.7 (0.3) 1.6 (0.3) <0.0001 
FEF25-75 (L/s)  3,078 2.0 (0.5) 2.1 (0.5) 0.017 
FEV1/FVC (%) 3,045 87.3 (6.8) 89.4 (6.0) <0.0001 
15 years (post -bronchodilation)     
FVC (L) 3,567 4.2 (0.9) 3.3 (0.6) <0.0001 
FEV1 (L) 3,433 3.8 (0.8) 3.1 (0.6) <0.0001 
FEF25-75 (L/s)  3,575 4.7 (1.2) 4.0 (1.0) <0.0001 
FEV1/FVC (%) 3,433 91.1 (6.6) 93.0 (6.3) <0.0001 
Lung function measures (z-scores)*     
  8 years (pre-bronchodilation)     
z-FVC (L) 2,807 -0.04 (1.1) -0.03 (1.0) 0.853 
z-FEV1 (L) 2,775 -0.03 (1.0) 0.02 (1.0) 0.173 
z-FEF25-75 (L/s)  2,807 -0.11 (1.1) -0.13 (1.0) 0.736 
z-FEV1/FVC (%) 2,775 0.03 (1.1) 0.07 (1.0) 0.322 
  15 years (post -bronchodilation)     
z-FVC (L) 3,245 -0.87 (1.3) -0.97 (1.3) 0.024 
z-FEV1 (L) 3,123 -0.34 (1.3) -0.58 (1.3) <0.0001 
z-FEF25-75 (L/s)  3,253 0.16 (1.1) 0.08 (1.2) 0.033 
z-FEV1/FVC (%) 3,123 0.91 (1.1) 0.76 (1.1) 0.0002 
Pre-bronchodilation lung function growth rates from age 8 to 
15 years ǂ    
 
FVC (mL/year) 3,073 325.5 (105.8) 214.4 (72.7) <0.0001 
FEV1 (mL/year) 3,013 293.8 (94.3) 200.7 (66.4) <0.0001 
FEF25-75 (mL/s·year)  3,070 327.4 (139.8) 234.2 (115.4) <0.0001 
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Definition of abbreviations: BMI, body mass index; FMI, fat mass index; LBMI, lean body mass index; P25-P75, 25th and
 75th percentiles 
p-value from the Mann-Whitney test comparing distributions across sexes 
Bold: p-value <0.05 
 
 
Table 2. Descriptive statistics of body weight and composition measures of the participants used to assess 
associations of body weight and composition trajectories with lung function at 15 years 
 n (N=3,575) Boys (n=1,687) Girls (n=1,888) p-value 
  Median (P25-P75) Median (P25-P75)  
Body weight measures     
BMI (kg/m2)      
7 years  3,261 15.8 (14.9-16.8) 15.9 (14.9-17.3) 0.007 
8 years  2,981 16.5 (15.5-17.9) 16.8 (15.5-18.5) 0.007 
9 years  3,323 16.8 (15.6-18.6) 17.3 (15.8-19.2) <0.0001 
10 years  3,363 17.3 (15.9-19.3) 17.7 (16.1-19.9) 0.002 
11 years  3,389 18.0 (16.5-20.4) 18.6 (16.8-21.0) <0.0001 
12 years  3,325 18.7 (17.1-21.0) 19.4 (17.6-21.8) <0.0001 
13 years  3,326 19.3 (17.7-21.5) 20.1 (18.4-22.4) <0.0001 
15 years  3,533 20.4 (18.8-22.5) 21.1 (19.4-23.4) <0.0001 
Body composition measures     
LBMI (kg/m2)      
9 years  3,197 13.0 (12.4-13.6) 12.1 (11.5-12.7) <0.0001 
11 years  3,361 13.3 (12.6-14.0) 12.7 (11.9-13.5) <0.0001 
13 years  3,293 14.9 (13.9-16.0) 13.4 (12.7-14.2) <0.0001 
15 years  3,516 16.3 (15.3-17.3) 13.6 (12.8-14.3) <0.0001 
FMI (kg/m2)      
9 years  3,197 3.0 (2.1-4.6) 4.3 (3.1-6.1) <0.0001 
11 years  3,361 3.7 (2.5-5.9) 4.9 (3.5-7.0) <0.0001 
13 years  3,293 3.1 (2.1-5.2) 5.7 (4.2-7.6) <0.0001 
15 years  3,516 2.8 (1.9-4.6) 6.5 (5.0-8.4) <0.0001 
